Skip to main content
Orchid Ventures, Inc. logo

Orchid Ventures, Inc. — Investor Relations & Filings

Ticker · ORVRF ISIN · CA68573L1076 LEI · 8945000TK5RMLOVX4I24 CSE Manufacturing
Filings indexed 252 across all filing types
Latest filing 2020-01-29 Regulatory Filings
Country CA Canada
Listing CSE ORVRF

About Orchid Ventures, Inc.

https://www.orchidessentials.com

Orchid Ventures, Inc. is a cannabis innovation company engaged in the design, development, manufacturing, branding, and distribution of branded cannabis vape products and proprietary hardware delivery systems. The company markets the "Orchid Essentials" brand, which includes comprehensive product lines featuring both tetrahydrocannabinol (THC) and cannabidiol (CBD) formulations. A key operational focus is the development of advanced delivery technology. This is executed through its subsidiary, PurTec Delivery Systems, which designs and sells proprietary, patent-pending hardware solutions to the cannabis and CBD sectors throughout North America. The company emphasizes clean product standards and mass-market appeal.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CFO of Orchid Ventures, Inc. regarding the interim financial report and interim MD&A for the period ended November 30, 2019. It is a Form 52-109FV2, which is a certification form used by venture issuers to attest to the accuracy and fair presentation of interim filings. The document does not contain actual financial data or the interim report itself, but rather a certification of those filings. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself. The document length is short (2932 characters), and it is clearly a certification letter, not the full interim report.
2020-01-29 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management’s Discussion and Analysis for Six Months Ended November 30, 2019' and contains detailed discussion of the company's financial performance, business strategy, risks, and operational overview for a six-month interim period. It references condensed consolidated interim financial statements prepared under IFRS and includes forward-looking statements and company overview. The length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. The content matches the typical characteristics of an Interim / Quarterly Report (IR), which includes substantive financial data and management analysis for a period shorter than a full fiscal year. There is no indication that this is merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2020
2020-01-29 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS AT AND FOR THE PERIOD ENDED NOVEMBER 30, 2019' and contains detailed unaudited interim financial statements including statements of financial position, loss and comprehensive loss, changes in shareholders' equity, and cash flows. It explicitly states it is an interim report prepared under IFRS IAS 34 Interim Financial Reporting. The document length is substantial (15,000 characters) and contains actual financial data and notes. There is no indication that this is merely an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2020
2020-01-29 English
News release - English.pdf
Regulatory Filings
2020-01-22 English
Report of exempt distribution excluding schedule 1 of Form 5 (amended).pdf
Regulatory Filings Classification · 100% confidence The document is titled 'Form 45-106F1 Report of Exempt Distribution' and references the British Columbia Securities Commission (BCSC) and Canadian securities regulations. It details information about securities distributions, purchasers, exemptions relied upon, and net proceeds. The form is a regulatory filing used to report exempt distributions of securities in Canada. It is not an annual report, earnings release, or any other financial statement but a specific regulatory compliance report related to securities distribution. The document is comprehensive and contains detailed data about the distribution, fitting the category of a Regulatory Filing (RNS).
2020-01-07 English
News release - English.pdf
Regulatory Filings
2019-11-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.